STAAR Surgical Announces Strategic Cooperation Agreement with Vista Oftalmólogos
February 28 2019 - 7:13AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, today announced a Strategic
Cooperation Agreement with Vista Oftalmólogos, a 49-clinic
ophthalmology group spanning Spain, France, Portugal and Morocco
with more than 200 eye doctors and 1,000 employees. The agreement
positions the EVO Visian ICL™ family of lenses as a premium and
primary refractive procedure for patients suffering from
nearsightedness (myopia), which is the need for distance vision
correction.
“Providing the highest level of science-backed vision services
to ensure satisfied patients is the common endeavor of every Vista
clinic and the EVO Visian ICL fulfills that goal fitting seamlessly
into our clinics,” said Mr. Juan Borreguero, Manager of Vista
Oftalmólogos. “Some of our surgeons have used the ICL for years
while others are just beginning the journey in providing this
life-changing vision correction solution to our patients. With the
ICL we have the added plus of a manufacturing company that meets
our surgeons’ expectations, which is no small feat in this
business. This new strategic cooperation agreement with STAAR
elevates the importance of the ICL in providing our patients a safe
quick vision correction procedure with unmatched levels of patient
satisfaction.”
EVO is the latest version of STAAR Surgical Company’s
implantable collamer lens (ICL) that works in harmony with the
patient’s natural eye to correct vision and provide patients visual
freedom from spectacles and contact lenses. The central hole of the
EVO lens allows for the eye’s natural nourishing aqueous flow and a
single surgical procedure. EVO is currently available in over 75
countries outside the U.S. in Aspheric, Toric (patients with
astigmatism), and EVO+ (patients with larger pupil sizes)
versions.
"In 10 short years Vista Oftalmólogos has established itself as
a leading ophthalmology group in Western Europe and we are
delighted they have chosen to make our EVO Visian ICL family of
lenses a premium and primary procedure in their clinics,” said
Caren Mason, President and CEO of STAAR Surgical Company.
“Precision manufactured with our exclusive Collamer® material the
EVO lens has a well-recognized safety and effectiveness record for
the more than 500,000 EVO lenses that have been implanted. The
STAAR team looks forward to working closely with Vista Oftalmólogos
on certifying surgeons, patient education and marketing to
facilitate broader awareness and use of the ICL.”
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 30 years, designs, develops, manufactures and markets
implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients,
lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR’s lens used in
refractive surgery is called an Implantable Collamer® Lens or
“ICL”, which includes the EVO Visian ICL™ product line. More than
900,000 Visian ICLs have been implanted to date. To learn more
about the ICL go to: www.discovericl.com. STAAR has approximately
475 full-time equivalent employees and markets lenses in over 75
countries. Headquartered in Monrovia, CA, with additional corporate
offices in Lake Forest, CA, the company operates manufacturing
facilities in Aliso Viejo, CA and Monrovia, CA. For more
information, please visit the Company’s website at
www.staar.com.
About Vista Oftalmólogos
We are ophthalmologists with more than 30 years of experience
treating patients and working to improve their living conditions,
putting their needs first. This is how Vista Oftalmólogos was born,
from the concern of prestigious medical professionals for offering
a high-quality ophthalmological service to a greater number of
people, through a modern organization that counts on the
participation of reference professionals at a national level who
have decided to join efforts to create a service of excellence.
During this time, we have consolidated prestigious clinics in the
different geographical areas in which we work, endowed with
advanced technologies and attended by a team of ophthalmologists
with more than 30 years of experience.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190228005458/en/
Investors & Media, STAAR SurgicalEVC GroupBrian
Moore, 310-579-6199Doug Sherk, 415-652-9100
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Aug 2024 to Sep 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Sep 2023 to Sep 2024